1. What would be the benefits or drawbacks of having one single regulatory agency versus the three separate existing agencies we currently have in place?
2. What is meant by the statement delicate dance of regulation and innovation?
3. How does the premarket phase in the regulatory process help companies, and how does it work to the benefit of the consumer?
4. The company 23andMe almost failed because of regulatory issues. What could product developers have done differently?
5. What are the potential benefits of modernizing the process of biotech regulation?